Getting Started
To fully participate in this online program you must be registered and logged in. Read all the information presented below. When ready select the "View Program" tab above.
Claiming CME/CE Credits
To receive CME/CE credits, participants must review the program materials in their entirety and complete the online post examination and evaluation with a score of 75% or better.
System Hardware/Software and Internet Connection Requirements
The following information is provided for your reference in conjunction with review of this program.
General System and Internet Requirements: Speakers or Headphones, High Speed Internet connection, Wireless 3G and 4G,
Web browsers: Internet Explorer 7.x or higher, Firefox 4.x or higher, Safari 2.x or higher and Chrome.Operating Systems: Windows 2000 or higher, (MS Surface and other MS mobile devices compatible), MAC OSX 10.3 or higher, Mac iOS 5.0 or higher (iPad, iPhone compatible), Android 4.3 or higher (most Android mobile devices compatible).
Digital breast tomosynthesis, also known as 3D DBT first entered the clinical arena in 2011 when the FDA approved its use. Multiple studies have since shown that tomosynthesis is effective in both the screening and the diagnostic setting. This technology has quickly emerged as a practice-changing standard by increasing both sensitivity and specificity, thereby improving breast cancer detection and the clinical accuracy of mammograms.
This Expert Forum educational program focuses on the impact of digital breast tomosynthesis and the role it plays in all aspects of breast screening. In this program, you will hear from an expert panel consisting of four (4) healthcare professionals from various specialties; who are all involved in the diagnosis, treatment and care of breast cancer patients and who will share their clinical insights and experience.
CME Effective Date: August 1, 2020
CME Expiration Date: July 31, 2022
CE Effective Date: November 5, 2020
CE Expiration Date: November 30, 2022
Format: Self Instructional - Audio Visual with Slides
Educational Credits:
Two (2) AMA/PRA Category 1 CME Credit™
Two (2) ARRT Category A CE Credit.
Two (2) AHRA CRA Credit
Estimated Completion Time: 2 hours
This program is supported through an unrestricted educational grant from FUJIFILM Medical Systems U.S.A., Inc.
This program is intended for: Radiologists, Other MD's, Radiologic Technologists, Radiology Administrators and related Imaging Professionals.
There is no cost to participate in this program.
Upon completion of this CME activity the healthcare provider should be able to:
No special educational preparation is required for this CME/CE Activity!
Amy Thurmond, MD
Radiologist
Women’s Imaging & Ultrasound
Oregon Health & Science University
Portland, Oregon
Dr. Thurmond has over 25-years’ experience in women's imaging and her professional accomplishments include international recognition for her research and continuing work in women's health and reproductive issues, including the development of Fallopian Tube Recanalization, a nonsurgical treatment of infertility.
Dr. Thurmond has published numerous articles and regularly presents her research at scientific meetings. However, Dr. Thurmond’s most important work is the day-to-day diagnosis of breast problems, abnormal vaginal bleeding, infertility, and other pelvic and pregnancy issues.
Lara Williams, MD, FACOG, IFMCP, FAARM
OB/GYN
Oregon Clinic for OB/GYN North
Portland, Oregon
Dr. William’s philosophy is to work in partnership with her patients; promoting physical and emotional health through nutrition, exercise, and medicine, while exploring both traditional and alternative routes to care.
Andy Cramer, MD, FACS
Surgical Oncologist
Clackamas Surgical Associates
Portland, Oregon
Dr. Cramer is a board-certified surgeon who was selected by Portland Monthly as one of the top surgeons in the Portland area in 2005, 2011 and 2015. Dr. Cramer is a member of the Oregon Medical Association, a Fellow of the American College of Surgeons, a member of the Christian Medical and Dental Association, and a member of the Society for Laparoscopic and Endoscopic Surgeons.
Lucy Langer, MD
Medical Oncologist
Compass Oncology
Portland, Oregon
Dr. Langer is also the Practice President and Director of Compass Oncology’s Genetic Risk Evaluation and Testing Program, and the Medical Director of Cancer Genetics for US Oncology.
In addition to her 18+ year experience in genetic research at some of the nation’s leading institutions, Dr. Langer has advanced subspecialty expertise in managing breast cancer, lung cancer and lymphomas. Dr. Langer believes strongly in evidence-based medicine and in being a steadfast advisor to her patients throughout their treatment journey.
Dr. Langer was recently named one of Portland’s Top Medical Providers in 2020 by Portland Monthly Magazine and in 2019 Dr. Langer was one of Portland’s Top Doctors by this same publication.
IAME requires everyone who is in a position to control the content of a CE/CME activity to disclose all relevant financial relationships with any commercial interest. This information is utilized to 1) determine if a conflict exists, 2) resolve the conflict by initiating a content validation process, and 3) advise learners of this information. Any individual who refuses to (or chooses not to) disclose relevant financial relationships will be disqualified from participating as an instructor, planner or manager and cannot have control of or responsibility for the development, management, presentation or evaluation of a CE/CME activity certified by IAME.
Amy Thuromnd, MD, discloses no relationship with commercial interests.
Lara Williams, MD, FACOG, IFMCP, FAARM, discloses no relationship with commercial interests.
Andy Cramer, MD, FACS, discloses no relationship with commercial interests.
Lucy Langer, MD, discloses no relationship with commercial interests.
No one at the Institute for Advanced Medical Education (IAME) or who had control of this activity has financial relationships with commercial supporters.
The Institute for Advanced Medical Education (IAME) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The Institute for Advanced Medical Education (IAME) designates this enduring material for a maximum of 2.0 AMA/PRA Category 1 CME Credits.™ Physicians should only claim credit commensurate with the extent of their participation in the activity.
Radiologic Technologists:
This course meets all criteria and has been approved by the AHRA, The Association for Medical Imaging Management for Two (2) ARRT Category A CE Credit.
Radiology Administrators:
This course meets all CRA renewal credit criteria and has been approved for Two (2) continuing education credit in the following CRA domains: Asset Resource Management (AM) and Operations Management (OM).
For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board or other credentialing organization.
CME Credits
To receive CME credits for participating in this CME activity you must successfully complete the online post examination with a passing score of 70% or higher.
CE Credits
To receive CE credits for participating in this CE activity you must successfully complete the online post examination with a passing score of 80% or higher.
Online examinations return an immediate grade report. Upon receiving a passing score click Continue and complete the evaluation form. To view and print your Statement of Credit click the Print/View Certificate button displayed from within your MyAR Archives page.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.